159 related articles for article (PubMed ID: 16868769)
1. [Cardiovascular prophylaxis through intensified insulin treatment. EDIC (Epidemiology of Diabetes Interventions and Complications)].
Scherbaum WA
Internist (Berl); 2006 Sep; 47(9):960-2. PubMed ID: 16868769
[No Abstract] [Full Text] [Related]
2. Insulin pump therapy, multiple daily injections, and cardiovascular mortality in 18,168 people with type 1 diabetes: observational study.
Steineck I; Cederholm J; Eliasson B; Rawshani A; Eeg-Olofsson K; Svensson AM; Zethelius B; Avdic T; Landin-Olsson M; Jendle J; Gudbjörnsdóttir S;
BMJ; 2015 Jun; 350():h3234. PubMed ID: 26100640
[TBL] [Abstract][Full Text] [Related]
3. Earlier intensified insulin treatment of Type 1 diabetes and its association with long-term macrovascular and renal complications.
Rathsman B; Donner M; Ursing C; Nyström T
Diabet Med; 2016 Apr; 33(4):463-70. PubMed ID: 26315152
[TBL] [Abstract][Full Text] [Related]
4. Glucose supply and insulin demand dynamics of antidiabetic agents.
Monte SV; Schentag JJ; Adelman MH; Paladino JA
J Diabetes Sci Technol; 2010 Mar; 4(2):365-81. PubMed ID: 20307399
[TBL] [Abstract][Full Text] [Related]
5. [Glycemic control and diabetic complications].
Yamada Y
Nihon Rinsho; 2005 Jun; 63 Suppl 6():604-8. PubMed ID: 15999778
[No Abstract] [Full Text] [Related]
6. Glycemic Control and Excess Cardiovascular Mortality in Type 1 Diabetes.
Teleb M; Popp Switzer M; Elhanafi S; Elfar A; San Juan ZT
Curr Cardiol Rep; 2016 Mar; 18(3):29. PubMed ID: 26886228
[TBL] [Abstract][Full Text] [Related]
7. Summaries for patients. The relationship between blood sugar levels and cardiovascular disease.
Ann Intern Med; 2004 Sep; 141(6):I12. PubMed ID: 15381536
[No Abstract] [Full Text] [Related]
8. The effect of intensive glycaemic control on cardiovascular outcomes.
Hill D; Fisher M
Diabetes Obes Metab; 2010 Aug; 12(8):641-7. PubMed ID: 20590740
[TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes, metabolic syndrome and cardiovascular risk.
Chillarón JJ; Flores Le-Roux JA; Benaiges D; Pedro-Botet J
Metabolism; 2014 Feb; 63(2):181-7. PubMed ID: 24274980
[TBL] [Abstract][Full Text] [Related]
10. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: overview.
Nathan DM;
Diabetes Care; 2014; 37(1):9-16. PubMed ID: 24356592
[TBL] [Abstract][Full Text] [Related]
11. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
Füchtenbusch M; Hummel M
MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
[No Abstract] [Full Text] [Related]
12. Causes of death in childhood-onset Type 1 diabetes: long-term follow-up.
Gagnum V; Stene LC; Jenssen TG; Berteussen LM; Sandvik L; Joner G; Njølstad PR; Skrivarhaug T
Diabet Med; 2017 Jan; 34(1):56-63. PubMed ID: 26996105
[TBL] [Abstract][Full Text] [Related]
13. Effect of glycemic treatment and microvascular complications on menopause in women with type 1 diabetes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort.
Kim C; Cleary PA; Cowie CC; Braffett BH; Dunn RL; Larkin ME; Gatcomb PM; Wessells HB; Nathan DM; Sarma AV;
Diabetes Care; 2014; 37(3):701-8. PubMed ID: 24170751
[TBL] [Abstract][Full Text] [Related]
14. [The study of development and progression of long-term complications in type I diabetes].
Araki E; Matsumura T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():134-9. PubMed ID: 12386984
[No Abstract] [Full Text] [Related]
15. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study.
Purnell JQ; Zinman B; Brunzell JD;
Circulation; 2013 Jan; 127(2):180-7. PubMed ID: 23212717
[TBL] [Abstract][Full Text] [Related]
16. The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study.
Cleary PA; Orchard TJ; Genuth S; Wong ND; Detrano R; Backlund JY; Zinman B; Jacobson A; Sun W; Lachin JM; Nathan DM;
Diabetes; 2006 Dec; 55(12):3556-65. PubMed ID: 17130504
[TBL] [Abstract][Full Text] [Related]
17. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: summary and future directions.
Gubitosi-Klug RA;
Diabetes Care; 2014; 37(1):44-9. PubMed ID: 24356597
[TBL] [Abstract][Full Text] [Related]
18. Insights from the diabetes control and complications trial/epidemiology of diabetes interventions and complications study on the use of intensive glycemic treatment to reduce the risk of complications of type 1 diabetes.
Genuth S
Endocr Pract; 2006; 12 Suppl 1():34-41. PubMed ID: 16627378
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort.
Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group
Diabetes Care; 1999 Jan; 22(1):99-111. PubMed ID: 10333910
[TBL] [Abstract][Full Text] [Related]
20. Insulin glargine in the treatment of type 1 and type 2 diabetes.
Barnett AH
Vasc Health Risk Manag; 2006; 2(1):59-67. PubMed ID: 17319470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
